SCHEMBL3858337

SCHEMBL3858337

COP(=O)(OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)C(O)C1O)OP(=O)(O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 5/20 0.62
P2RY2 P41231 3/20 0.62
DNPH1 O43598 3/20 0.62
ADORA1 P30542 2/20 0.62
SRC P12931 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
TRPM2 O94759 2/20 0.62
PRKAB2 O43741 1/20 0.62
LDHA P00338 1/20 0.62
ADRB2 P07550 1/20 0.62
FBP1 P09467 1/20 0.62
PRKAG1 P54619 1/20 0.62
PRKAA2 P54646 1/20 0.62
PDE4D Q08499 1/20 0.62
KCNH2 Q12809 1/20 0.62
PRKAA1 Q13131 1/20 0.62
PDE3A Q14432 1/20 0.62
TAS1R3 Q7RTX0 1/20 0.62
TAS1R1 Q7RTX1 1/20 0.62
P2RY11 Q96G91 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3862068 0.96 P2RX3 (0.61) P2RY1P2RY2DNPH1ADORA1SRC
SCHEMBL1905822 0.89 P2RX3 (0.72) P2RY1P2RY2DNPH1ADORA1SRC
SCHEMBL1905818 0.89 P2RX3 (0.72) P2RY1P2RY2DNPH1ADORA1SRC
SCHEMBL3859612 0.89 P2RY1 (0.67) P2RY1P2RY2DNPH1ADORA1SRC
Thioinosine Monophosphate SCHEMBL379366 0.89 DNPH1 (0.77) P2RY1P2RY2DNPH1ADORA1SRC
Thioinosine Monophosphate SCHEMBL15810629 0.89 DNPH1 (0.77) P2RY1P2RY2DNPH1ADORA1SRC
Thioinosine Monophosphate SCHEMBL379365 0.89 DNPH1 (0.77) P2RY1P2RY2DNPH1ADORA1SRC
Thioinosine Monophosphate SCHEMBL29746215 0.89 DNPH1 (0.77) P2RY1P2RY2DNPH1ADORA1SRC
SCHEMBL1906288 0.88 P2RY1 (0.74) P2RY1P2RY2DNPH1ADORA1SRC
SCHEMBL1906291 0.88 P2RY1 (0.74) P2RY1P2RY2DNPH1ADORA1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825254-A4 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LAB INC (US) 2009-01-14 EP disclosed
EP-1825254-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY Prometheus Laboratories, Inc. (US) 2007-08-29 EP disclosed
US-20060216726-A1 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry PROMETHEUS LABORATORIES INC. (US) 2006-09-28 US disclosed
WO-2006055527-A2 METHOD FOR OPTIMIZING THIOPURINE EFFICACY AND TOXICITY USING MASS SPECTROMETRY PROMETHEUS LABORATORIES INC. (US) 2006-05-26 WO disclosed